Chester Chae

Chester Chae is a seasoned professional in regulatory affairs, currently serving as Senior Manager at BlossomHill Therapeutics, Inc. since January 2025. Prior to this role, Chester held positions as Manager of Regulatory Affairs at ORIC Pharmaceuticals Inc. from March 2022 to December 2024 and at Sorrento Therapeutics, Inc. from March 2021 to March 2022. Chester's experience also includes a tenure as Senior Associate in CMC Regulatory Affairs at Amgen from May 2019 to March 2021 and serving as a Consultant for Injector Devices Technical Due Diligence at BioMarin Pharmaceutical Inc. from August 2018 to May 2019. Chester Chae holds a Master's degree in Biotechnology from Keck Graduate Institute and a Bachelor's degree in Chemistry from Hanover College.